12 Jan SAHPRA signs MoU with Medicines Control Authority of Zimbabwe
Pretoria, 12 January 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ).
The MoU between SAHPRA and MCAZ will allow the regulators to develop a cooperative partnership towards ensuring access to safe, quality, and effective health products in the respective countries.
Areas of cooperation
SAHPRA and MCAZ will cooperate in joint products reviews and inspections to enable efficient access to health products. This partnership will also focus on detection and curbing of substandard and falsified health products moving between the two countries, which has off late been a major challenge that the two regulators have identified.
“The forging of partnerships such as this MoU with the Medicines Control Authority of Zimbabwe, a fellow African National Regulatory Authority, is key to further enhancing and building capacity on the continent”, indicates SAHPRA CEO, Dr Boitumelo Semete-Makokotlela.
“This landmark event marks a significant step towards strengthening the regulatory frameworks of both Zimbabwe and South Africa in the pharmaceutical sector. The MoU is designed to facilitate cooperation and collaboration between the two countries in the areas of medicines regulation, quality control, and pharmacovigilance”, shares MCAZ Director-General, Mr Richard Rukwata.